There have been 50 recent insider transactions recorded for Recursion Pharmaceuticals, Inc. (RXRX), including 10 buys and 33 sells. Total insider buying was valued at $842.46K and total insider selling at $7.87M.
Notable insiders with recent activity include Li Dean Y, Dar Zavain, Gibson Christopher. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — RXRX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Li Dean Y |
Director |
RSU Award |
3,268 |
- |
- |
1,244,177 |
| 2026-04-01 |
Dar Zavain |
Director |
RSU Award |
4,902 |
- |
- |
147,231 |
| 2026-03-23 |
Gibson Christopher |
Director |
Informative Sell |
40,000 |
$3.25 |
$130K |
906,556 |
| 2026-03-17 |
Taylor Ben R |
Chief Financial Officer |
Informative Sell |
7,956 |
$3.39 |
$26.97K |
1,180,318 |
| 2026-03-16 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
7,075 |
$3.42 |
$24.2K |
1,188,274 |
| 2026-03-09 |
Gibson Christopher |
Director |
Gift (Given) |
20,000 |
- |
- |
906,556 |
| 2026-03-09 |
Khan Najat |
CEO and President |
Informative Sell |
28,298 |
$3.35 |
$94.66K |
2,262,085 |
| 2026-03-03 |
Borgeson Blake |
Director |
Informative Sell |
170,000 |
$3.46 |
$588.2K |
6,259,863 |
| 2026-02-19 |
Gibson Christopher |
Director |
Informative Sell |
40,000 |
$3.46 |
$138.4K |
906,556 |
| 2026-02-18 |
Taylor Ben R |
Chief Financial Officer |
Informative Sell |
13,426 |
$3.08 |
$41.35K |
1,195,349 |
| 2026-02-17 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
11,908 |
$3.49 |
$41.56K |
1,208,775 |
| 2026-02-17 |
Gibson Christopher |
Director |
Tax Withholding of RSU |
27,265 |
$3.49 |
$95.15K |
906,556 |
| 2026-02-17 |
Hallett David |
Chief Scientific Officer |
Tax Withholding of RSU |
11,908 |
$3.49 |
$41.56K |
1,097,151 |
| 2026-02-17 |
Khan Najat |
CEO and President |
Tax Withholding of RSU |
14,280 |
$3.49 |
$49.84K |
2,290,383 |
| 2026-02-06 |
Gibson Christopher |
Director |
Tax Withholding of RSU |
10,364 |
$3.56 |
$36.9K |
933,821 |
| 2026-02-06 |
Taylor Ben R |
Chief Financial Officer |
RSU Award |
446,279 |
- |
- |
1,207,829 |
| 2026-02-06 |
Hallett David |
Chief Scientific Officer |
RSU Award |
502,064 |
- |
- |
1,096,205 |
| 2026-02-06 |
Khan Najat |
CEO and President |
RSU Award |
1,673,546 |
- |
- |
2,284,681 |
| 2026-02-04 |
Gibson Christopher |
Director |
Informative Sell |
40,000 |
$4.12 |
$164.8K |
913,839 |
| 2026-02-03 |
Borgeson Blake |
Director |
Informative Sell |
220,000 |
$4.20 |
$924K |
6,429,863 |
| 2026-01-20 |
Gibson Christopher |
Director |
Informative Sell |
40,000 |
$4.47 |
$178.8K |
913,839 |
| 2026-01-06 |
Borgeson Blake |
Director |
Informative Sell |
220,000 |
$4.36 |
$959.2K |
6,649,863 |
| 2026-01-05 |
Gibson Christopher |
Director |
Gift (Given) |
20,000 |
- |
- |
913,839 |
| 2026-01-02 |
Li Dean Y |
Director |
RSU Award |
2,381 |
- |
- |
1,240,909 |
| 2026-01-02 |
Dar Zavain |
Director |
RSU Award |
3,571 |
- |
- |
142,329 |
| 2026-01-01 |
Hallett David |
CSO |
Unknown |
70,037 |
$7.25 |
$507.77K |
- |
| 2025-12-29 |
Taylor Ben R |
Chief Financial Officer |
Informative Sell |
21,383 |
$4.18 |
$89.38K |
761,550 |
| 2025-12-22 |
Khan Najat |
Chief R&d Commercial Officer |
Informative Sell |
124,403 |
$4.41 |
$548.59K |
611,135 |
| 2025-12-19 |
Gibson Christopher |
Chief Executive Officer |
Informative Sell |
40,000 |
$4.50 |
$180K |
913,839 |
| 2025-12-15 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
7,057 |
$4.33 |
$30.56K |
782,933 |
| 2025-12-04 |
Gibson Christopher |
Chief Executive Officer |
Gift (Given) |
20,000 |
- |
- |
913,839 |
| 2025-12-02 |
Borgeson Blake |
Director |
Informative Sell |
220,000 |
$4.37 |
$961.4K |
6,869,863 |
| 2025-11-25 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
2,271 |
$4.03 |
$9.15K |
789,990 |
| 2025-11-19 |
Gibson Christopher |
Chief Executive Officer |
Informative Sell |
40,000 |
$4.16 |
$166.4K |
913,839 |
| 2025-11-17 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
11,908 |
$4.14 |
$49.3K |
792,261 |
| 2025-11-17 |
Gibson Christopher |
Chief Executive Officer |
Tax Withholding of RSU |
40,390 |
$4.14 |
$167.21K |
913,839 |
| 2025-11-17 |
Khan Najat |
Chief R&d Commercial Officer |
Tax Withholding of RSU |
17,584 |
$4.14 |
$72.8K |
735,538 |
| 2025-11-05 |
Khan Najat |
Chief R&d Commercial Officer |
RSU Award |
169,851 |
$4.96 |
$842.46K |
169,851 |
| 2025-11-04 |
Gibson Christopher |
Chief Executive Officer |
Gift (Given) |
20,000 |
- |
- |
954,229 |
| 2025-10-23 |
Gibson Christopher |
Chief Executive Officer |
Informative Sell |
100,000 |
$5.70 |
$570K |
954,229 |
| 2025-10-10 |
Gibson Christopher |
Chief Executive Officer |
Gift (Given) |
20,000 |
- |
- |
954,229 |
| 2025-10-01 |
Li Dean Y |
Director |
RSU Award |
1,961 |
- |
- |
1,238,528 |
| 2025-10-01 |
Dar Zavain |
Director |
RSU Award |
2,941 |
- |
- |
138,758 |
| 2025-09-25 |
Gibson Christopher |
Chief Executive Officer |
Informative Sell |
100,000 |
$4.76 |
$476K |
954,229 |
| 2025-09-15 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
7,057 |
$4.83 |
$34.09K |
804,169 |
| 2025-09-10 |
Gibson Christopher |
Chief Executive Officer |
Gift (Given) |
20,000 |
- |
- |
954,229 |
| 2025-08-26 |
Gibson Christopher |
Chief Executive Officer |
Informative Sell |
100,000 |
$4.84 |
$484K |
954,229 |
| 2025-08-18 |
Khan Najat |
Chief R&d Commercial Officer |
Informative Sell |
36,599 |
$5.52 |
$202.17K |
668,197 |
| 2025-08-15 |
Taylor Ben R |
Chief Financial Officer |
Tax Withholding of RSU |
11,908 |
$5.64 |
$67.16K |
811,226 |
| 2025-08-15 |
Gibson Christopher |
Chief Executive Officer |
Tax Withholding of RSU |
40,390 |
$5.64 |
$227.8K |
954,229 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
